Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

UBE2N Regulates Oncoprotein Networks in Myeloid Malignancies

Chiharu Ishikawa, Laura Barreyro, Avery Sampson, Kathleen Hueneman, Kwangmin Choi, Lyndsey C. Bolanos, Andrew Volk, Stephanie S Watowich, Kenneth Greis, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 2762.

https://doi.org/10.1182/blood-2023-187438

Published: 2023

Journal Articles

The Mechanism of Therapy Resistance By Lineage Plasticity in AML and How to Overcome It

Sean Walulik, Sarai Dean, Eric J Vick, Xiaoqin Zhu, Mark Wunderlich, Chih-Hsing Chou, Kwangmin Choi, H. Leighton Grimes, Daniel T. Starczynowski, Linde A. Miles, Andrew Volk

Blood (2023) 142 (Supplement 1): 1410.

https://doi.org/10.1182/blood-2023-186180

Published: 2023

Journal Articles

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery Sampson, Emma Uible, Eric Vick, Lyndsey C. Bolanos, Kathleen Hueneman, Mark Wunderlich, Amal Kolt, Kwangmin Choi, Andrew Volk, Kenneth D. Greis, Jan Rosenbaum, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski

Blood (2023) 142 (11): 989–1007.

https://doi.org/10.1182/blood.2022018718

Published: 2023

Includes: Supplemental data

Journal Articles

UBE2N Is a Druggable Target and an Essential Ubiquitin-Conjugating Enzyme in Myeloid Malignancies

Chiharu Ishikawa, Laura Barreyro, Avery Sampson, Kathleen Hueneman, Kwangmin Choi, Lyndsey C Bolanos, Andrew Volk, Kenneth D Greis, Daniel T. Starczynowski

Blood (2022) 140 (Supplement 1): 5830.

https://doi.org/10.1182/blood-2022-167336

Published: 2022

Journal Articles

TRIM13 Is a Novel Cell Cycle Hub Regulated By CHAF1B to Promote Acute Myeloid Leukemogenesis

Sarai Dean, Chiharu Ishikawa, Xiaoqin Zhu, Timothy Nixon, Sean Walulik, Michael Wyder, Jessica Jordan, Mark Wunderlich, Daniel T. Starczynowski, Nathan Salomonis, Ken Greis, Andrew Volk

Blood (2022) 140 (Supplement 1): 2978–2979.

https://doi.org/10.1182/blood-2022-169879

Published: 2022

Journal Articles

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

Josh Bennett, Jennifer Yeung, Avery Sampson, Kathleen Hueneman, Mark Wunderlich, Kwangmin Choi, Andrew Volk, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski

Blood (2022) 140 (Supplement 1): 2240–2241.

https://doi.org/10.1182/blood-2022-167526

Published: 2022

Journal Articles

Ticket to divide: m 6 A reader YTHDC1 drives acute myeloid leukemia proliferation

Andrew Volk

Blood (2021) 138 (26): 2748–2750.

https://doi.org/10.1182/blood.2021013185

Published: 2021

Journal Articles

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

Christian Marinaccio, MSc, Praveen K Suraneni, PhD, Hamza Celik, PhD, Andrew Volk, PhD, Jeremy Q. Wen, MD PhD, Te Ling, PhD, Terra Lasho, PhD, Richard P. Koche, PhD, Christopher Famulare, MS, Brady L. Stein, MD, Sandeep Gurbuxani, MBBS, PhD, Ronald Hoffman, MD, Naseema Gangat, MBBS, Navdeep Chandel, Ross L. Levine, MD, Raajit K. Rampal, MD PhD, Grant Challen, Ayalew Tefferi, MD, John D. Crispino, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-140557

Published: 2020

Journal Articles

A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemic Pathogenesis

Andrew Volk, PhD, Kaiwei Liang, PhD, Jianyun Zhao, Xinyu Li, Marinka Bulic, Stacy Marshall, Jeffrey W. Taub, MD, Yubin Ge, PhD, Sebastien Malinge, PhD, Elizabeth Bartom, PhD, Ali Shilatifard, PhD, John D. Crispino, PhD

Blood (2017) 130 (Supplement 1): 245.

https://doi.org/10.1182/blood.V130.Suppl_1.245.245

Published: 2017

Journal Articles

Sensitizing Acute Myeloid Leukemia Cells to Interferon-Induced Differentiation By Inhibiting RIP1/RIP3 Necroptotic Pathway

Blood (2014) 124 (21): 3752.

https://doi.org/10.1182/blood.V124.21.3752.3752

Published: 2014

Journal Articles

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

Andrew Volk, Jing Li, PhD, Junping Xin, PhD, Dewen You, PhD, Jun Zhang, PhD, Peter Breslin, PhD, Zejuan Li, MD, PhD, Wei Wei, Rachel Schmidt, Xinyu Li, MD, Zhou Zhang, PhD, Paul C Kuo, MD, Sucha Nand, MD, Jianke Zhang, PhD, Jianjun Chen, PhD, Jiwang Zhang, MD, PhD

Blood (2013) 122 (21): 2890.

https://doi.org/10.1182/blood.V122.21.2890.2890

Published: 2013

Journal Articles

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Dewen You, PhD, Andrew Volk, Clare Sun, MD, Junping Xin, MD, PhD, Geunhyoung Ha, PhD, Chunliu Pan, PhD, Rachel Schmidt, Patience Oladeinde, Wei Wei, Subing Zhang, MD, Eun-Kyoung Breuer, PhD, Peter Breslin, PhD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 864.

https://doi.org/10.1182/blood.V120.21.864.864

Published: 2012

Journal Articles

Sensitizing Leukemic Cells to NF-κB Inhibitor Treatment by Repressing TNFα-Mediated, NF-κB-Independent Survival Signaling

Andrew Volk, Yechen Xiao, PhD, Junping Xin, PhD, Dewen You, PhD, Rachel Schmidt, Shubin Zhang, Wei Wei, Peter Breslin, PhD, Sucha Nand, MD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 1878.

https://doi.org/10.1182/blood.V120.21.1878.1878

Published: 2012

Journal Articles

TNF-α/Fas-RIP-1–induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations

Yechen Xiao, Hongling Li, Jun Zhang, Andrew Volk, Shubin Zhang, Wei Wei, Shanshan Zhang, Peter Breslin, Jiwang Zhang

Blood (2011) 118 (23): 6057–6067.

https://doi.org/10.1182/blood-2011-06-359448

Published: 2011

Includes: Supplemental data

Journal Articles

TNF-α/Fas-RIP-1-Induced Cell Death Signaling Separates Hematopoietic Stem Cells/Progenitors Into Two Distinct Populations

Yechen Xiao, Andrew Volk, Shubin Zhang, Wei Wei, Peter Breslin, Jiwang Zhang

Blood (2011) 118 (21): 393.

https://doi.org/10.1182/blood.V118.21.393.393

Published: 2011

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

UBE2N Regulates Oncoprotein Networks in Myeloid Malignancies

The Mechanism of Therapy Resistance By Lineage Plasticity in AML and How to Overcome It

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

UBE2N Is a Druggable Target and an Essential Ubiquitin-Conjugating Enzyme in Myeloid Malignancies

TRIM13 Is a Novel Cell Cycle Hub Regulated By CHAF1B to Promote Acute Myeloid Leukemogenesis

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

Ticket to divide: m 6 A reader YTHDC1 drives acute myeloid leukemia proliferation

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemic Pathogenesis

Sensitizing Acute Myeloid Leukemia Cells to Interferon-Induced Differentiation By Inhibiting RIP1/RIP3 Necroptotic Pathway

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Sensitizing Leukemic Cells to NF-κB Inhibitor Treatment by Repressing TNFα-Mediated, NF-κB-Independent Survival Signaling

TNF-α/Fas-RIP-1–induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations

TNF-α/Fas-RIP-1-Induced Cell Death Signaling Separates Hematopoietic Stem Cells/Progenitors Into Two Distinct Populations

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only